Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Objective: We examined public health nurses' beliefs about the safety of dispensing hormonal contraceptives in the home, the extent to which they considered contraceptive dispensing within their scope of practice, and the types of support needed to effectively dispense contraceptives in the home.
Design And Sample: We conducted focus groups in Washington State with 24 home visiting nurses participating in a Nurse Family Partnership (NFP) randomized clinical trial in which nurses dispensed hormonal contraceptives during home visits.
Measures: We assessed the feasibility of the intervention and barriers and facilitators to home dispensing of hormonal contraceptives.
Results: Nurses were, on average 52 years old and had been working in nursing approximately 25 years, with between 5 and 18 years of experience working in a family planning setting. Overall, nurses believed that, with the right training and support, dispensing of hormonal contraceptives in the home was safe and fit within their scope of practice. Those nurses who reported resistance to the intervention cited inadequate training, lack of clear protocols, and sufficient support as important deterrents.
Conclusions: Home-based contraceptive dispensing by nurses is a feasible enhancement of the NFP program. To ensure that nurses are confident and able to dispense hormonal contraceptives, training, clinical protocols, consultation, and logistical support are needed.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/phn.12150 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Use of progestin-only drospirenone-based pills in hyperandrogenic women with polycystic ovary syndrome.
Arch Gynecol Obstet
September 2025
Department of Women's and Children's Health Sciences and Public Health, Fondazione Policlinico Universitario A. Gemelli, IRCCS, L.Go Agostino Gemelli, 8, 00168, Rome, Italy.
Purpose: Polycystic ovarian syndrome (PCOS) is a common endocrine-metabolic disorder affecting about 10% of reproductive-age women. Characterized by hyperandrogenism and ovulatory dysfunction, PCOS often involves metabolic features due to insulin resistance. Traditional treatment with combined oral contraceptive pills (COCP) effectively manages hyperandrogenism and menstrual irregularities.
View Article and Find Full Text PDFMedical treatment of fibroids: FIGO best practice guidance.
Int J Gynaecol Obstet
September 2025
Department of Gynecology and Obstetrics, Justus Liebig University Giessen, Giessen, Germany.
Even though uterine fibroids are a widespread condition, the range of approved medical treatment options remains limited. In fact, only a few drugs are officially approved for the therapy of fibroids. In both the USA and the European Medicines Agency region, selected gonadotropin-releasing hormone (GnRH) antagonists have been approved for this indication.
View Article and Find Full Text PDFThe Effects of Covid-19 Vaccination on Menstruation: Are women with underlying reproductive health conditions, particularly black women at a higher risk for vaccine-related menstruation complications?
J Healthc Sci Humanit
January 2024
University of Texas Health, Austin Pediatric Neurosciences at Dell Children's Hospital, 512-628-1855.
The study investigates the potential impact of COVID-19 vaccines on menstrual cycles, with a particular focus on Black women and those with underlying reproductive health conditions. Despite numerous reports of menstrual irregularities post-vaccination, research on this subject remains limited. The study aims to explore whether these irregular cycles could indicate broader reproductive health concerns, such as reduced ovarian reserve, and whether certain vaccines are more likely to cause these changes.
View Article and Find Full Text PDFGender-Affirming Care and Gynecology: Best Practices for Supporting Youth Who Are Transgender and Gender Diverse.
Pediatr Ann
September 2025
Division of Gynecology, Boston Children's Hospital, Department of Surgery, Harvard Medical School.
Based on extensive evidence, gender-affirming care (GAC) is endorsed by numerous medical societies as the gold standard for supporting youth who are transgender and gender diverse (TGD). Unfortunately, there remain barriers to accessing GAC and an ongoing risk of gender identity-based mistreatment for youth who are TGD accessing all forms of health care. Gynecologic care is commonly accessed by youth who are TGD as part of medical gender affirmation, with needs ranging from hormone management, menstrual suppression, contraception counseling, and surgical consultation.
View Article and Find Full Text PDFInjectable contraceptive continuation and user experiences in Punjab, Pakistan: a non-randomized prospective cohort study protocol.
BMC Womens Health
September 2025
Jhpiego, Islamabad, Pakistan.
Background: Evidence from multiple pilots and post-introduction scale-up initiatives have demonstrated that self-administered subcutaneous depot-medroxyprogesterone acetate (DMPA-SC) has potential to improve contraceptive continuation rates and expand contraceptive access to populations with limited utilization of facility-based health services. Only a few of these studies have been conducted in South Asian countries, and none where most contraceptive use is of non-hormonal methods that require limited to no contact with the health system, leaving policymakers in countries like Pakistan with limited context-specific evidence to guide decisions on whether, how, and for whom to introduce DMPA-SC.
Methods: A prospective cohort study will be conducted in 41 health facilities and surrounding communities in Punjab, Pakistan.